Merck Opens Asia Pacific Headquarters In Singapore
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm’s total investment in the country is more than $650 million.
You may also be interested in...
Asia Set To Become New Center Of Pharma: PricewaterhouseCoopers Report
China and India seen as countries with the highest growth potential.
Genentech Boosts Singapore Presence With $140 Million Biologics Plant
Lilly also increases R&D efforts in nation with a $150 million expansion.
Singapore Biomedical Sciences Group Director Yeoh Keat Chuan: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
Singapore government official talks about the country’s R&D strengths and how it is handling increased competition from other Asian nations.